San Diego, October 16, 2026 / PRNewswire / -- Shareholder Rights Law Firm Robbins LLP reminds investors that it has filed a class action on behalf of all individuals who purchased or otherwise acquired D-Wave ( NYSE : QBTS ) securities between February 26, 2026, and August 25, 2026 (including both dates), referred to hereinafter as the "class action period." D-Wave is a company engaged in quantum computing.
The complaint alleges that D-Wave exaggerated its business and financial prospects.
Robbins LLP Investors who purchased D- Wave Quantum Inc securities during the class action period and suffered significant losses should contact this law firm before December 15, 2026, to obtain information regarding the lawsuit.
D-Wave Why was it sued?
According to the complaint, during the class action period, the defendant failed to disclose the following matters:
- The defendant seriously exaggerated the business and financial prospects of D-Wave.
- The aforementioned situation is likely to have a negative impact on the company's business and reputation;
- Therefore, all the public statements made by the defendant at all relevant times were significantly false and misleading.
Why did the stock price of __BJW_KEEP_00001 fall?
According to the complaint, the truth began to emerge on August 6, 2026. On that day, D-Wave announced its financial results for the second quarter of 2026. Among other things, D-Wave reported revenue of only $3.08 million, compared to $3.10 million in the same period of the previous year, which was lower than analysts' expectations of $4.03 million to $4.08 million. Affected by this news, the stock price of D-Wave fell by $1.99 per share on August 6, 2026, a decrease of 9.28%, closing at $19.41 per share.
Subsequently, on August 25, 2026, D-Wave issued a press release announcing that John Markovich would retire and therefore step down from the position of Chief Financial Officer, effective September 2, 2026. Affected by this news, the stock price of D-Wave fell by $1.84 per share, a decrease of 9.51%, and closed at $17.51 per share on August 26, 2026.
What can shareholders do now? D-Wave
Investors who purchased D- Wave Quantum Inc securities during the class action period may be eligible to serve as the lead plaintiff. The lead plaintiff is an investor designated by the court to represent the interests of all class members throughout the litigation process. Shareholders interested in applying to be the lead plaintiff should contact Robbins LLP before the deadline of December 15, 2026, to learn about the appointment procedure.
Shareholders do not need to act as the lead plaintiffs, but they can also share in any potential compensation. Investors who have not applied for appointment can still serve as absent collective members.
Is there a fee involved for participation?
Not required. Robbins LLP represents investors on a risk agency basis, does not charge any upfront fees, and investors are not required to bear any out-of-pocket expenses or costs.
Contact Robbins LLP
Investors who wish to learn more about the class action lawsuit regarding D- Wave Quantum Inc securities can submit inquiries, send emails to attorneys Aaron Dumas, Jr, or call (800) 350-6003 to contact Robbins LLP.
Why choose Robbins LLP?
Robbins LLP indicates that, as a leading law firm recognized in the field of shareholder rights litigation, the firm has represented clients in securities fraud and shareholder derivative litigation cases, helping shareholders to recover over $2 billion in value and achieving some of the largest compensation outcomes in the history of shareholder derivative litigation.
"Enterprises have the obligation to provide investors with complete and accurate information in order for the market to function fairly and efficiently," stated Robbins LLP, co-founder of Brian J. Robbins.
If you wish to receive notifications when a settlement is reached in the class action regarding D- Wave Quantum Inc, or to get free alerts when there is improper behavior by company executives, you can register for Stock Watch.
Lawyer advertisement. Past results do not guarantee similar outcomes.
